This company develops a wearable device that continuously monitors vital signs for signs of opioid overdose. When an overdose is detected, the device automatically alerts emergency services and designated contacts, enabling rapid intervention and potentially preventing fatalities.
Funding
Funding not disclosed
Founders
Product
Problem
Opioid overdoses often occur in unsupervised settings, leading to delayed intervention and increased risk of fatalities. Current methods for detecting and responding to overdoses rely on timely intervention by bystanders, which is not always possible or reliable.
Solution
NOMW Health is developing an AI-powered wearable device designed for the early detection and management of opioid overdoses. The device continuously monitors the wearer's vital signs for indicators of an overdose. Upon detection, the device automatically triggers an alert to emergency services and designated contacts, facilitating a rapid response. This technology aims to reduce overdose-related fatalities by enabling timely intervention, even when the individual is alone or incapacitated.
Target Audience
The primary target audience includes individuals at high risk of opioid overdose, such as those with a history of opioid use disorder, individuals taking prescription opioids for pain management, and those in clinical or recreational settings where opioid use is prevalent.
Features
- Continuous monitoring of vital signs indicative of opioid overdose, such as respiratory rate and heart rate.
- AI-powered algorithms for real-time detection of overdose events.
- Automated alerts to emergency services and designated contacts upon overdose detection.
- Wearable form factor for continuous and unobtrusive monitoring.